WHAT WE DO
The vast majority of cervical cancer cases are caused by infections of the human papillomavirus (HPV) that develop into detectable precancerous lesions.
While these lesions are completely treatable, cervical cancer is the third most common cancer among women and the fourth leading cause of cancer-related deaths in women worldwide.
Globally, it is estimated that more than 500,000 cases and 250,000 deaths occur annually due to cervical cancer and greater than 85% of these cases occur in developing countries.
Cervical cancer remains a leading cause of cancer death in many countries around the world, with 90% of the mortality disproportionately affecting women in low- and middle-income countries.
BHI conducts research to improve screening and prevention practices and shares its findings with the public health community. This has led to over 30 published papers since 2005. BHI receives research funding from the NIH, UICC, PATH and private foundations, and has worked in El Salvador, Haiti, Dominican Republic, Colombia, and Peru. It will soon begin working in Mexico.Read more +
Implementation and Outreach
BHI is now expanding its programs into new regions in the countries we currently work, and developing materials on how to best replicate these models in other settings.Read more +
Advocacy and Policy
BHI participates in international meetings with the goal of disseminating the findings from studies it conducts, participating in the development of national guidelines which have international impact. It also hosts national symposium / stakeholder meetings in El Salvador and Haiti.Read more +
BHI trains health care professionals in low-tech, low-cost screening and treatment methods appropriate for use in low-resource settings. To date, BHI has trained over 2,500 health care professionals, who have used these skills throughout El Salvador, Guatemala, Haiti, and the Dominican Republic.
BHI offers free cervical cancer screening and treatment for cases of pre-cancer. BHI also provides arrangements for treatment, transportation, food and housing for all the women they have identified as having cervical cancer. To date, BHI with the support of their partners, has screened over 45,000 women and has treated over 4,000 women.